Skip to main content

Peer Review reports

From: Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFRT790M/C797S/L858R and EGFRT790M/L858R

Original Submission
1 Oct 2023 Submitted Original manuscript
4 Oct 2023 Author responded Author comments - Linxiao Wang
Resubmission - Version 2
4 Oct 2023 Submitted Manuscript version 2
16 Oct 2023 Reviewed Reviewer Report - Manikanta Murahari
27 Oct 2023 Reviewed Reviewer Report
29 Oct 2023 Reviewed Reviewer Report
2 Mar 2024 Author responded Author comments - Linxiao Wang
Resubmission - Version 3
2 Mar 2024 Submitted Manuscript version 3
12 Mar 2024 Author responded Author comments - Linxiao Wang
Resubmission - Version 4
12 Mar 2024 Submitted Manuscript version 4
31 Mar 2024 Reviewed Reviewer Report
6 Apr 2024 Reviewed Reviewer Report - Manikanta Murahari
30 Jun 2024 Author responded Author comments - Linxiao Wang
Resubmission - Version 5
30 Jun 2024 Submitted Manuscript version 5
3 Jul 2024 Author responded Author comments - Linxiao Wang
Resubmission - Version 6
3 Jul 2024 Submitted Manuscript version 6
17 Jul 2024 Author responded Author comments - Linxiao Wang
Resubmission - Version 7
17 Jul 2024 Submitted Manuscript version 7
24 Jul 2024 Author responded Author comments - Linxiao Wang
Resubmission - Version 8
24 Jul 2024 Submitted Manuscript version 8
14 Aug 2024 Author responded Author comments - Linxiao Wang
Resubmission - Version 9
14 Aug 2024 Submitted Manuscript version 9
Publishing
22 Aug 2024 Editorially accepted
27 Aug 2024 Article published 10.1186/s13065-024-01279-z

You can find further information about peer review here.

Back to article page